Stevanato Group (NYSE:STVN) Trading 0.3% Higher – Here’s What Happened

Stevanato Group S.p.A. (NYSE:STVN) was up 0.3% during trading on Wednesday . The company traded as high as €23.95 ($25.21) and last traded at €23.75 ($25.00). Approximately 175,372 shares changed hands during mid-day trading, a decline of 65% from the average daily volume of 499,712 shares. The stock had previously closed at €23.67 ($24.92).

Analysts Set New Price Targets

A number of brokerages have recently commented on STVN. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America upped their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Finally, Wolfe Research assumed coverage on Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($30.11).

Stevanato Group Trading Down 1.1 %

The firm’s fifty day moving average is €19.87 and its 200 day moving average is €19.73. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last announced its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The business had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. During the same quarter in the previous year, the company earned $0.16 EPS. Stevanato Group’s revenue for the quarter was up 2.4% compared to the same quarter last year. On average, research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Schwartz Investment Counsel Inc. boosted its stake in Stevanato Group by 12.3% during the second quarter. Schwartz Investment Counsel Inc. now owns 126,281 shares of the company’s stock worth $2,316,000 after buying an additional 13,800 shares in the last quarter. Raymond James Trust N.A. increased its stake in Stevanato Group by 18.7% in the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after acquiring an additional 1,613 shares during the period. Liontrust Investment Partners LLP acquired a new position in Stevanato Group in the second quarter worth about $6,104,000. Conestoga Capital Advisors LLC lifted its stake in Stevanato Group by 7.3% during the second quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock worth $133,439,000 after purchasing an additional 496,930 shares during the period. Finally, Natixis Advisors LLC boosted its holdings in Stevanato Group by 27.3% during the second quarter. Natixis Advisors LLC now owns 42,674 shares of the company’s stock valued at $783,000 after purchasing an additional 9,146 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.